Great Point Partners LLC Vanda Pharmaceuticals Inc. Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $4.32 Million - $5.93 Million	-309,800 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$14.05 - $20.2 $6.85 Million - $9.85 Million	-487,731 Reduced 61.16%	309,800 $0
Q4 2017 Feb 14, 2018	BUY	$12.85 - $18.1 $3.86 Million - $5.43 Million	300,000 Added 60.3%	797,531 $12.1 Million
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $7.66 Million - $9.38 Million	497,531	497,531 $8.91 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.